Regulatory differences between countries are an important driver of the cross-border trade in assisted reproduction as people move to seek services unavailable in their home countries. The development of a lucrative global trade in non-medical sex selection needs to be considered in ethical debates over its availability. I suggest that depictions of non-medical sex selection as a means of 'family balancing' or supportive of reproductive autonomy serve to distance the technologies rhetorically from the gender stereotyping inherent in their use and the commodification upon which they depend. They construct new social categories such as the 'unbalanced' family, the pathologization of 'gender disappointment' and a limited and highly individualized definition of reproductive freedom that permits medical interventions on healthy bodies. Orientalism pervades ethical debate depicting non-medical sex selection in the West as more acceptable to practices in 'Asia'. A case study of the interconnections between Australia and Thailand highlights the global economy sustaining the practice. © 2011, Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Australia cross-border reproductive care preimplantation genetic diagnosis non-medical sex selection Thailand

Sex Preselection Australia health care policy commodification Thailand human travel medical ethics reproductive rights family health field study family decision making Humans genetic screening female Prenatal Diagnosis prenatal genetic diagnosis artificial selection Preimplantation Diagnosis clinical article pregnancy Conference Paper Prejudice medical tourism market Reproductive Health